From : Demirci, Hasan <hasan.demirci@roche.com>
To : Tamar Gabunia <tgabunia@moh.gov.ge>
Subject : Update and increase in production of COVID-19 PCR tests
Cc : Ayhan Isler {Sale~Ankara Dia} <ayhan.isler@roche.com>; Anzor tchavtchavadze <atchavtchavadze@moh.gov.ge>; Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Tinatin Khardziani <tkhardziani@moh.gov.ge>; Kanybekova, Zhanar <zhanar.kanybekova@roche.com>; Arsenat Toishybayev <arsenat.toishybayev@roche.com>
Received On : 29.03.2021 12:01

Dear Ms. Gabunia,

I hope this email finds you well and COVID is now much better manageable in Georgia.

It has been a while and I wanted to update you regarding our supply in instruments and reagents. We have installed both cobas 6800's and everything is running as planned. We have assigned our colleagues both from Kazakhstan and Russia to make a smooth installation and training in time. 

In the mean time, our global colleagues have improved the processes and with additional investments a significant increase has been achieved in reagents manufacturing. I gladly inform you that in a couple of months we will be able to provide with higher test amounts for Georgia, up to 13,000 tests per week. This can bring a significant efficiency by consolidating more tests on fewer instruments.

I hope spring and summer bring better days ahead with new diagnosis, prevention and treatment options. We are always in your disposal to support you in managing the pandemic.

Kind regards.

Hasan Demirci
Head of 
Central Asia and Caucasian Countries
Roche Diagnostics

Roche Kazakhstan LLP
137, Luganskiy Street, Medeuskiy District
Almaty, 050051
Kazakhstan

Tel   
   
: +
7 (727) 321 24 24
 
Mobile
 
: +7 (701) 351 91 69

________________________________________________________
Confidentiality Note:  This message is intended only for the use of the named recipients and may contain confidential and/or privileged information.  If you are not the intended recipient, please contact the sender and delete this message. Any unauthorized use of the information contained in this message is prohibited.